Evaluation of Saussurea lappa on Oxidative Stress and Cognition in Aluminium-induced Alzheimer’s Disease Rats
DOI:
https://doi.org/10.18311/jnr/2024/43482Keywords:
Acetylcholinesterase (AChE), Catalase, Learning, Memory, Oxidative Stress, Saussurea lappaAbstract
Background: Oxidative stress and neurodegenerative illnesses, such as Alzheimer's disease (AD), are closely associated. There has been a lot of thought put into finding medicinal plants with nootropic properties to slow the onset and course of AD. Objective: The study aimed to evaluate the methanolic extract of Saussurea lappa clarke (MESC) on oxidative stress and cognitive ability induced by aluminium exposure. Methods: Wistar albino rats were chosen for the study. About 30 animals were selected and grouped into 5 with 6 animals in each group. Group I served as control, group II served as disease induced (Aluminium-induced), group III, IV and V were administered with standard drug – Donepezil Hcl, and MESC at two doses – 200 and 400 mg/kg. The behavioural studies were examined by using certain apparatus like Passive Avoidance (PA) test, Elevated Plus Maze, Y- Maze and Actophotometer. Determination of anti-oxidant enzymes – Catalase (CAT) and thiobarbituric acid reactive substances (TBARS) along with acetylcholinesterase (AChE) levels which was done in rat’s brain homogenate. Results: In the PA test, administration of MESC at doses of 200 and 400 mg/kg significantly (**p< 0.01) lengthened step-through latency (STL) in rats on day 30 compared to the positive control group. Animals at MESC (200 & 400 mg/kg) showed noticeably higher memory retention (MR) rates as compared to the disease-control group. Additionally, administration of MESC (200 and 400 mg/kg) significantly (**p< 0.01) raised CAT and declined the concentration of TBARS. AChE concentration was significantly (**p< 0.01) reduced at the dose of MESC at 200 and 400 mg/kg as compared to the positive control group. Conclusion: The present study showed that MESC had a strong nootropic effect on brain antioxidant indicators and cognitive function in rats exposed to aluminium-induced oxidative stress and cognitive impairment. These findings may be investigated in the treatment of neurodegenerative diseases, including AD.
Downloads
Metrics
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Humera Sadia, Govindu Sumalatha (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Accepted 2024-08-01
Published 2024-10-07
References
Mehla J, Gupta P, Pahuja M, Diwan D, Diksha D. Indian medicinal herbs, and formulations for Alzheimer’s disease, from traditional knowledge to scientific assessment. Brain Sci. 2020; 10(12):964. https://doi.org/10.3390/ brainsci10120964 PMid:33321899 PMCid:PMC7764187
2020 Alzheimer’s disease facts and figures. Alzheimers Dement. 2020 Mar 10. Epub ahead of print. https://doi.org/10.1002/alz.12068 PMid:32157811
Anand P, Singh B. A review on cholinesterase inhibitors for Alzheimer’s disease. Arch Pharm Res. 2013; 36(4):375-99. https://doi.org/10.1007/s12272-013-0036-3 PMid:23435942
Rao PS and Mohan GK. In vitro alpha-amylase inhibition and in vivo antioxidant potential of momordica dioica seeds in streptozotocin-induced oxidative stress in diabetic rats. Saudi Journal of Biological Sciences. 2017; 24(6):1262-7. https://doi.org/10.1016/j.sjbs.2016.01.010 PMid:28855820
Rahman T, Hosen I, Islam MMT, Shekhar HU. Oxidative stress and human health. Adv Biosci Bio Technol. 2012; (3):997-1019. https://doi.org/10.4236/abb.2012.327123
Gella A, Durany N. Oxidative stress in alzheimer disease. Cell Adh Migr. 2009; 3(1):88-93. https://doi.org/10.4161/ cam.3.1.7402 PMid:19372765
Tamagno E, Guglielmotto M, Vasciaveo V, Tabaton M. Oxidative stress and beta amyloid in Alzheimer’s disease. Which comes first: The chicken or the egg? Antioxidants (Basel). 2021; 10(9):1479. https://doi.org/10.3390/ antiox10091479 PMid:34573112
Huang WJ, Zhang X, Chen WW. Role of oxidative stress in Alzheimer’s disease. Biomed Rep. 2016; 4(5):519-22. https://doi.org/10.3892/br.2016.630 PMid:27123241
Sailaja Rao P, Sireesha Kalva, Aparna Yerramilli, Sadanandam Mamidi. Free radicals and tissue damage: role of antioxidants. free radicals and antioxidants. 2011; 1(4):27. https://doi.org/10.5530/ax.2011.4.2
Halliwell B. Free radicals in the brain. Springer Berlin Heidelberg; New York, NY: 1992. Reactive oxygen species and the central nervous system. 1992. p. 21-40. https://doi.org/10.1007/978-3-642-77609-0_2
Smith KJ, Kapoor R, Felts PA. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol. 1999; 9(1):69-92. https://doi.org/10.1111/j.1750-3639.1999.tb00212.x PMid:9989453
Clarke JR, Lyra E Silva NM, Figueiredo CP, Frozza RL, Ledo JH, Beckman D, Katashima CK, Razolli D, Carvalho BM, Frazão R, Silveira MA, Ribeiro FC, Bomfim TR, Neves FS, Klein WL, Medeiros R, LaFerla FM, Carvalheira JB, Saad MJ, Munoz DP, Velloso LA, Ferreira ST, De Felice FG. Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation. EMBO Mol Med. 2015; 7(2):190-210. https://doi.org/10.15252/emmm.201404183 PMid:25617315
Perluigi M, Coccia R, Butterfield DA. 4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neuro degenerative diseases: a toxic combination illuminated by redox proteomics studies. Antioxid Redox Signal. 2012; 17(11):1590-609. https://doi.org/10.1089/ars.2011.4406 PMid:22114878
AbuArrah M, Yuli Setianto B, Faisal A, Hamim Sadewa A. 8-Hydroxy-2-Deoxyguanosine as Oxidative DNA Damage biomarker of medical ionizing radiation: A scoping review. J Biomed Phys Eng. 2021; 11(3):389-402. https://doi.org/10.31661/jbpe.v0i0.2101-1258 PMid:34189127
Kandimalla R, Vallamkondu J, Corgiat EB, Gill KD. Understanding aspects of aluminum exposure in Alzheimer’s disease development. Brain Pathol. 2016; 26(2):139-54. https://doi.org/10.1111/bpa.12333 PMid:26494454
Abdel-Rahman M, Rezk MM, Ahmed-Farid OA, Essam S, Abdel Moneim AE. Saussurea lappa root extract ameliorates the hazards effect of thorium induced oxidative stress and neuroendocrine alterations in adult male rats. Environ Sci Pollut Res Int. 2020; 12:13237-46. https://doi.org/10.1007/s11356-020-07917-y PMid:32016872
Islam F, Khadija JF, Harun-Or-Rashid M, et al. Bioactive compounds and their derivatives: an insight into prospective phytotherapeutic approach against Alzheimer’s disease. Oxid Med Cell Longev. 2022; 5100904. https://doi.org/10.1155/2022/5100904 PMid:35450410
El-Rahman GIA, Behairy A, Elseddawy NM, et al. Saussurea lappa ethanolic extract attenuates triamcinolone acetonide-induced pulmonary and splenic tissue damage in rats via modulation of oxidative stress, inflammation, and apoptosis. Antioxidants (Basel). 2020; 9(5):396. https://doi.org/10.3390/antiox9050396 PMid:32397156
Chinedu E, Arome D, Ameh FS. A new method for determining acute toxicity in animal models. Toxicol Int. 2013; 20(3):224-6. https://doi.org/10.4103/09716580.121674 PMid:24403732
Eagle AL, Wang H, Robison AJ. Sensitive assessment of hippocampal learning using temporally dissociated passive avoidance task. Bio Protoc. 2016; 6(11):1821. https://doi.org/10.21769/BioProtoc.1821 PMid:29119127
Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. 2007; 2(2):322-8. https://doi.org/10.1038/nprot.2007.44 PMid:17406592
Bhosale U, Yegnanarayan R, Prachi P, Zambare M, Somani RS. Study of CNS depressant and behavioral activity of an ethanol extract of achyranthes aspera (Chirchita) in mouse model. Ann Neurosci. 2011; 18(2):44-7. https://doi.org/10.5214/ans.0972.7531.1118204 PMid:25205920
Carbone L, Carbone ET, Yi EM, et al. Assessing cervical dislocation as a humane euthanasia method in mice. J Am Assoc Lab Anim Sci. 2012; 51(3):352-6.
Khan RA, Khan MR, Sahreen S. Brain antioxidant markers, cognitive performance and acetylcholinesterase activity of rats: efficiency of sonchus asper. Behav Brain Funct. 2012; 8:21. https://doi.org/10.1186/1744-9081-8-21 PMid:22591917
Patro G, Bhattamisra SK, Mohanty BK, Sahoo HB. In vitro and in vivo antioxidant evaluation and estimation of total phenolic, flavonoidal content of Mimosa pudica L. Pharmacognosy Res. 2016; 8(1):22-8. https://doi.org/10.4103/0974-8490.171099 PMid:26941532
Freitas AP, Santos CR, Sarcinelli PN, Silva Filho MV, Hauser-Davis RA, Lopes RM. Evaluation of a brain acetylcholinesterase extraction method and kinetic constants after methyl-paraoxon inhibition in three brazilian fish species. PLoS One. 2016; 11(9):0163317. https://doi.org/10.1371/journal.pone.0163317 PMid:27655611
Snyder JM, Radaelli E, Goeken A, et al. Perfusion with 10% neutral-buffered formalin is equivalent to 4% paraformaldehyde for histopathology and immune his to chemistry in a mouse model of experimental autoimmune encephalomyelitis. Vet Pathol. 2022; 59(3):498-505. https://doi.org/10.1177/03009858221075588 PMid:35130806
Nardi L, Schmeisser MJ, Schumann S. Fixation and staining methods for macroscopical investigation of the brain. Front Neuroanat. 2023: 17:1200196. https://doi.org/10.3389/ fnana.2023.1200196 PMid:37426902
Sadia H, Sumalatha G. In vitro antioxidant activity and gas chromatography-mass spectrometry analysis of methanolic extracts of Saussurea lappa Clarke and Premna mucronata Rox b. Int J Pharm Sci Drug Res. 2022; 14(6):788-9. https:// doi.org/10.25004/IJPSDR.2022.140617
Dos Santos-Neto LL, de Vilhena Toledo MA, MedeirosSouza P, de Souza GA. The use of herbal medicine in Alzheimer’s disease - A systematic review. Evid Based Complement Alternat Med. 2006; 3(4):441-5. https://doi.org/10.1093/ecam/nel071 PMid:17173107
Mantle D, Pickering AT, Perry E. Medical plant extracts for treatment of dementia: A review of their pharmacology, efficacy and tolerability. CNS Drugs. 2000; 13:201-13. https://doi.org/10.2165/00023210-200013030-00006
Cummings J, Aisen PS, DuBois B, Frölich L, Jack CR Jr, Jones RW, Morris JC, Raskin J, Dowsett SA, Scheltens P. Drug development in Alzheimer’s disease: the path to 2025. Alzheimers Res Ther. 2016; (8):39. https://doi.org/10.1186/ s13195-016-0207-9 PMid:27646601
Skalny AV, Aschner M, Jiang Y, et al. Molecular mechanisms of aluminum neurotoxicity: Update on adverse effects and therapeutic strategies. Adv Neurotoxicol. 2021; 5:1-34. https://doi.org/10.1016/bs.ant.2020.12.001 PMid:34263089
Cheng H, Yang B, Ke T, et al. Mechanisms of metal-induced mitochondrial dysfunction in neurological disorders. toxics. 2021; 9(6):142. https://doi.org/10.3390/toxics9060142 PMid:34204190 PMCid:PMC8235163
Jomova K, Vondrakova D, Lawson M, Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem. 2010; 345(1-2):91-104. https://doi.org/10.1007/s11010-010-0563-x PMid:20730621
Bryliński Ł, Kostelecka K, Woliński F, et al. Aluminium in the human brain: Routes of penetration, toxicity, and resulting complications. Int J Mol Sci. 2023; 24(8):7228. https://doi.org/10.3390/ijms24087228 PMid:37108392
Atallah HE, Frank MJ, O’Reilly RC. Hippocampus, cortex, and basal ganglia: insights from computational models of complementary learning systems. Neurobiol Learn Mem. 2004; 82(3):253-67. https://doi.org/10.1016/j.nlm.2004.06.004 PMid:15464408
Nandi A, Yan LJ, Jana CK, Das N. Role of catalase in oxidative stress- and age-associated degenerative diseases. Oxid Med Cell Longev. 2019; 9613090. https://doi.org/10.1155/2019/9613090 PMid:31827713
Lardinois OM. Reactions of bovine liver catalase with superoxide radicals and hydrogen peroxide. Free Radic Res. 1995; 22(3):251-74. https://doi.org/10.3109/10715769509147544 PMid:7757201
Anand P, Singh B. A review on cholinesterase inhibitors for Alzheimer’s disease. Arch Pharm Res. 2013; 36(4):375-99. https://doi.org/10.1007/s12272-013-0036-3 PMid:23435942